(Q42505006)

1 November 2017

Adenoid cystic/basal cell carcinoma of the prostate strongly expresses HER-2/neu (English)

1 reference

1 November 2017

K A Iczkowski

1

1 reference

1 November 2017

R Montironi

series ordinal

2

1 reference

1 November 2017

language of work or name

English

0 references

publication date

1 December 2006

1 reference

Journal of Clinical Pathology

1 November 2017

1 reference

1 November 2017

59

1 reference

1 November 2017

12

1 reference

1 November 2017

1327-1330

1 reference

Basal cell hyperplasia and basal cell carcinoma of the prostate: a comprehensive review and discussion of a case with c-erbB-2 expression

1 November 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1860524

Basal cell proliferations of the prostate other than usual basal cell hyperplasia: a clinicopathologic study of 23 cases, including four carcinomas, with a proposed classification

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1860524

Adenoid cystic/basal cell carcinoma of the prostate: clinicopathologic findings in 19 cases

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1860524

HER-2/neu is overexpressed infrequently in patients with prostate carcinoma. Results from the California Cancer Consortium Screening Trial

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1860524

Prognostic significance of HER-2/neu gene amplification status by fluorescence in situ hybridization of prostate carcinoma

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1860524

Correlation of her-2/neu gene amplification with other prognostic and predictive factors in female breast carcinoma

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1860524

Prostate cancer overexpresses CD44 variants 7-9 at the messenger RNA and protein level

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1860524

Evaluation of HER-2/neu expression in prostatic adenocarcinoma: a requested for a standardized, organ specific methodology

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1860524

c-erbB-2 Oncogene Expression in Salivary Gland Tumours

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1860524

Adenoid cystic carcinoma of the trachea and bronchus--a clinicopathologic study with DNA flow cytometric analysis and oncogene expression

1 December 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/17142577

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

[What is the real importance of evaluating the expression of c-erbB-2 (HER-2/neu) in carcinoma of the breast and prostate? (A short review)]

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/17142577

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Dedifferentiated adenoid cystic carcinoma: a clinicopathologic study of 6 cases

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/17142577

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1136/JCP.2005.035147

1 reference

1 November 2017

1 reference

1 November 2017

PubMed publication ID

17142577

1 reference